Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes

Journal of Clinical Investigation

Volumn 98, Issue 5, 1996, Pages 1133-1141

  Bianchi, Elisabetta ^a   Ferrero, Elisabetta ^a   Fazioli, Francesca ^a   Mangili, Francesca ^a   Wang, Jin ^b   Bender, Jeffrey R ^b   Blasi, Francesco ^a,c   Pardi, Ruggero ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

cell adhesion molecules; cell movement; cyclic AMP; neoplasms; plasminogen activators

Indexed keywords

INTEGRIN; PROTEIN KINASE C; UROKINASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LYMPHOCYTE MIGRATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

EID: 0029757446     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118896     Document Type: Article

References (53)

1. Picker, J.L., and E.C. Butcher. 1992. Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol. 10:561-592.
2. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:301-314.
3. Dustin, L.M., and T.A. Springer. 1989. T cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature (Lond.). 341:619-624.
4. Vassalli, J.D., A.P. Sappino, and D. Belin. 1991. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1067-1072.
5. Conese, M., and F. Blasi. 1995. The urokinase/urokinase receptor system and cancer invasion. Bailliere's Clin. Haematology. 8:365-389.
6. Kramer, M.D., B. Schaefer, and J. Reinartz. 1995. Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences. Biol. Chem. Hoppe-Seyler. 376:131-141.
7. r 55,000 form of the human plasminogen activator urokinase. J. Cell Biol. 100:86-92.
8. Stoppelli, M.P., A. Corti, A. Soffientini, G. Cassani, F. Blasi, and R.K. Assoian. 1985. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl. Acad. Sci. USA. 82:4939-4943.
9. Roldan, A.L., M.V. Cubellis, M.T. Masucci, N. Behrendt, L.R. Lund, K. Danø, E. Appella, and F. Blasi. 1990. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO (Eur. Mol. Biol. Organ.) J. 9:467-474.
10. Estreicher, A., J. Mühlhauser, J.-L. Carpentier, L. Orci, and J.-D. Vassalli. 1990. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol. 111:783-792.
11. Min, H.Y., R. Semnani, I.F. Mizukami, K. Watt, R.F.I. Todd, and D.Y. Liu. 1992. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J. Immunol. 148:3632-3642.
12. Miles, L.A., and E.F. Plow. 1987. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells. Thromb. Haemost. 58:936-942.
13. Nykjaer, A., C.M. Petersen, B. Møller, P.A. Andreasen, and J. Glieman. 1992. Identification and characterization of urokinase receptors in natural killer cells and in T-cell-derived lymphokine activated killer cells. FEBS Lett. 300:13-17.
14. Nykjaer, A., B. Møller, R.F.I. Todd, T. Christensen, P.A. Andreasen, J. Gliemann, and C.M. Petersen. 1994. Urokinase Receptor. An activation antigen in human T lymphocytes. J. Immunol. 152:505-516.
15. Resnati, M., M. Guttinger, S. Valcamonica, N. Sidenius, F. Blasi, and F. Fazioli. 1996. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO (Eur. Mol. Biol. Organ.) J. 15:1572-1582.
16. 2-terminal domain of the urokinase receptor. FEBS Lett. 288:233-236.
17. Wysocki, L.J., and V.L. Sato. 1978. Panning for lymphocytes. A method for cell separation. Proc. Natl. Acad. Sci. USA. 75:2844-2848.
18. Appella, E., Robinson, E.A., Ullrich, S.J., Stoppelli, M.P., Corti, A., Cassani, G., and F. Blasi. 1987. The receptor binding sequence of urokinase. A biological function for the growth factor module of proteases. J. Biol. Chem. 262:4437-4440.
19. Blasi, F. Surface receptors for urokinase plasminogen activators. 1988. Fibrinolysis. 2:73-84.
20. Imboden, J.B., and J.D. Stobo. 1985. Transmembrane signaling by the T cell antigen receptor: perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J. Exp. Med. 161:446-456.
21. Szamel, M., and K. Resch. 1995. T-cell antigen receptor-induced signal transduction pathways. Activation and function of protein kinases C in T lymphocytes. Eur. J. Biochem. 228:1-15.
22. Pardi, R., J.R. Bender, C. Dettori, F. Giannazza, and E.G. Engleman. 1989. Heterogeneous distribution and transmembrane signaling properties of lymphocyte function-associated antigen (LFA-1) in human lymphocyte subsets. J. Immunol. 143:3157-3166.
23. Kanner, S.B., L.S. Grosmaire, J.A. Ledbetter, and N.K. Damle. 1993. β2-integrin LFA-1 signaling through phospholipase C-γ1 activation. Proc. Natl. Acad. Sci. USA. 90:7099-7103.
24. Rovere, P., L. Inverardi, J.R. Bender, and R. Pardi. 1996. Feedback modulation of ligand-engaged αL/β2 leukocyte integrin (LFA-1) by cyclic AMP-dependent protein kinase. J. Immunol. 156:2273-2279.
25. Pardi, R., L. Inverardi, C. Rugarli, and J.R. Bender. 1992. Antigen-receptor complex stimulation triggers protein kinase C-dependent CD11a/ CD18-cytoskeleton association in T Lymphocytes. J. Cell Biol. 116:1211-1220.
26. Imhof, B.A., and D. Dunon. 1995. Leukocyte migration and adhesion. Adv. Immunol. 58:345-416.
27. Rosales, C., and R.L. Juliano. 1995. Signal transduction by cell adhesion receptors in leukocytes. J. Leuk. Biol. 57:189-198.
28. Werb, Z., P.M. Tremble, O. Behrendtsen, E. Crowley, and C.H. Damsky. 1989. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol. 109:877-889.
29. Seftor, R.E., E.A. Seftor, W.G. Stetler-Stevenson, and M.J. Hendrix. 1993. The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. Cancer Res. 53:3411-3415.
30. Larjava, H., J.G. Lyons, T. Salo, M. Makela, L. Koivisto, H. Birkedal-Hansen, S.K. Akiyama, and J. Heino. 1993. Anti-integrin antibodies induce type IV collagenase expression in keratinocytes. J. Cell. Physiol. 157:190-200.
31. Romanic, A.M., and J.A. Madri. 1994. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J. Cell Biol. 125:1165-1178.
32. Clipstone, N.A., and G.R. Crabtree. 1993. Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506. Ann. NY Acad. Sci. 696:20-30.
33. Siebenlist, U., G. Franzoso, and K. Blown. 1994. Structure, regulation and function of NF-kB. Annu. Rev. Cell Biol. 10:405-455.
34. Genot, E.M., P.J. Parker, and D.A. Cantrell. 1995. Analysis of the role of protein kinases C-alpha, -epsilon and -zeta in T cell activation. J. Cell Biol. 270:9833-9839.
35. Soravia, E., A. Grebe, P. De Luca, K. Helin, T.T. Suh, J.L. Degen, and F. Blasi. 1995. A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene. Blood. 86:624-635.
36. Langer, D.J., A. Kuo, K. Kariko, M. Ahuja, B.D. Klugherz, K.M. Ivanics, J.A. Hoxie, W.V. Williams, B.T. Liang, D.B. Cines, and E.S. Bainathan. 1993. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways. Circ. Res. 72:330-340.
37. Vassalli, J.D., and D. Belin. 1987. Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett. 214:187-191.
38. Leppert, D., E. Waubant, R. Galardy, N.W. Bunnet, and S.L. Hauser. 1995. T cell gelatinase mediate basement membrane transmigration in vitro. J. Immunol. 154:4379-4389.
39. Fulton, R.J., and D.A. Hart. 1980. Detection and partial characterization of lymphoid cell surface proteases. Cell. Immunol. 55:394-405.
40. Bristow, C.L., L.K. Lyford, D.P. Stevens, and P.M. Flood. 1991. Elastase is a constituent product of T-cells. Biochem. Biophys. Res. Commun. 181:232-239.
41. Vlodavsky, I., A. Eldor, H.-F. A., Y. Matzner, R. Ishai-Michaeli, O. Lider, Y. Naparstek, I.R. Cohen, and Z. Fucks. 1992. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis. 12:112-127.
42. Ossowski, L., and E. Reich. 1983. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell. 35:611-619.
43. Miginatti, P., E. Robbins, and D.B. Rifkin. 1986. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell. 47:487-498.
44. Ossowski, L. 1988. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase. J. Cell Biol. 107: 2437-2445.
45. Hearing, V.J., L.W. Law, A. Corti, E. Appella, and F. Blasi. 1988. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res. 48:1270-1278.
46. Ossowski, L., H. Russo-Payne, and E.L. Wilson. 1991. Inhibition of urokinase-type plasminogen activator by antibodies: The effect on dissemination of a human tumor in the nude mouse. Cancer Res. 51:274-281.
47. Crowley, C.W., R.L. Cohen, B.K. Lucas, G. Liu, M.A. Shuman, and A.D. Levinson. 1993. Prevention of metastasis by inhibition of the urokinase receptor. Proc. Natl. Acad. Sci. USA 90:5021-5025.
48. Kobayashi, H., J. Gotoh, M. Fujie, H. Shinohara, N. Moniwa, and T. Terao. 1994. Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within the growth factor-like domain of urokinase in the experimental and spontaneous matastasis model. Int. J. Cancer. 57:723-733.
49. Kramer, M.D., H. Spring, R. Todd, and U. Vettel. 1994. Urokinase-type plasminogen activator enhances invasion of human T cells (Jurkat) into a fibrin matrix. J. Leuk. Biol. 56:110-116.
50. Waltz, D.A., and H.A. Chapman. 1994. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem. 269:14746-14750.
51. Pyke, C., P. Kristensen, E. Ralfkiaer, J. Grøndahl-Hansen, J. Eriksen, F. Blasi, and K. Danø. 1991. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am. J. Path. 138:1059-1067.
52. Pyke, C., N. Graem, E. Ralfkiaer, E. Rønne, G. Høyer-Hansen, N. Brünner, and K. Danø. 1993. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res. 53:1911-1915.
53. Bianchi, E., R.L. Cohen, A.T. Thor, R.F.I. Todd, I.F. Mizukami, D.A. Lawrence, B.M. Ljung, M.A. Shuman, and H.S. Smith. 1994. The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res. 54:861-866.